Neutrophil Survival and Demise During Inflammatory States

炎症状态下中性粒细胞的存活和死亡

基本信息

  • 批准号:
    10651795
  • 负责人:
  • 金额:
    $ 61.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-16 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

Abstract Interleukin-1b is a pro-inflammatory cytokine in cardiovascular disease (CVD) contributing to life-threatening cardiovascular events including myocardial infarction and stroke. Interleukin-1a also contributes to disease. The cell types and signaling pathways that control IL-1a/b production remains to be comprehensively evaluated. This study will investigate the neutrophil lineage in cardiovascular disease and their role in IL-1a/b production. Neutrophil accumulation in tissues is a hallmark feature of many acute and chronic inflammatory diseases, including coronary artery disease. Despite our broad understanding of the factors controlling neutrophil production and function, we lack a comprehensive understanding of cell death signaling in the neutrophil lineage at steady state and during inflammation. In patients with coronary artery disease, neutrophils accumulate in atherosclerotic plaques, and are enriched in areas that are prone to rupture and intraplaque hemorrhage. In mouse models of coronary artery disease (CAD), atherosclerotic plaques feature an accumulation of neutrophils in early and advanced stages of disease, and neutrophil depletion impairs the early recruitment of monocytes to the aortic arch and the progression of atherosclerosis. We hypothesize that neutrophils release IL-1 in CAD by engaging the NLRP3 inflammasome, the Caspase-8-regulated apoptosis pathway, or the MLKL-regulated necroptotic pathway. The control of Caspase-8-dependent apoptosis and IL-1 release by Bcl-2 family members will be evaluated in neutrophil lineage cells including neutrophil progenitors (NePs), immature neutrophils, and mature neutrophils. The effects of CAD on IL-1 production and cell death signaling in human neutrophil lineage cells will be assessed. This research will identify pro-survival signals in coronary artery disease increasing neutrophil longevity, and pro-death signals that control IL-1 production, formation of neutrophil extracellular traps, release of mitochondria, and inflammatory forms of cell death.
摘要 白细胞介素-1b是心血管疾病(CVD)中的促炎细胞因子,可导致危及生命的 心血管事件,包括心肌梗死和中风。白细胞介素-1a也有助于疾病。的 控制IL-1 a/B产生的细胞类型和信号通路仍有待全面评估。这 本研究将研究心血管疾病中的中性粒细胞谱系及其在IL-1 a/B产生中的作用。 组织中的神经元积聚是许多急性和慢性炎性疾病的标志性特征, 包括冠心病。尽管我们对控制中性粒细胞的因素有广泛的了解, 生产和功能,我们缺乏对中性粒细胞系细胞死亡信号的全面了解 在稳定状态和炎症期间。在冠状动脉疾病患者中, 动脉粥样硬化斑块,并在易于破裂和斑块内出血的区域富集。在 冠状动脉疾病(CAD)的小鼠模型,动脉粥样硬化斑块以中性粒细胞的积累为特征 在疾病的早期和晚期,中性粒细胞耗竭损害单核细胞的早期募集, 主动脉弓和动脉粥样硬化的进展。我们假设冠心病患者中性粒细胞通过 参与NLRP 3炎性体,半胱天冬酶-8调节的凋亡途径,或MLKL调节的凋亡途径。 坏死性凋亡途径Bcl-2家族成员对Caspase-8依赖的细胞凋亡和IL-1释放的调控 将在中性粒细胞谱系细胞中进行评价,包括中性粒细胞祖细胞(NeP)、未成熟中性粒细胞和 成熟中性粒细胞冠心病对人中性粒细胞系IL-1产生及细胞死亡信号的影响 将对细胞进行评估。这项研究将确定冠状动脉疾病中的促生存信号, 中性粒细胞寿命,和控制IL-1产生的促死亡信号,中性粒细胞胞外陷阱的形成, 线粒体的释放和细胞死亡的炎性形式。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HAROLD M HOFFMAN其他文献

HAROLD M HOFFMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HAROLD M HOFFMAN', 18)}}的其他基金

Innate immune mechanisms of the host response to Coccidioides
宿主对球孢子菌反应的先天免疫机制
  • 批准号:
    10356728
  • 财政年份:
    2022
  • 资助金额:
    $ 61.15万
  • 项目类别:
Innate immune mechanisms of the host response to Coccidioides
宿主对球孢子菌反应的先天免疫机制
  • 批准号:
    10554376
  • 财政年份:
    2022
  • 资助金额:
    $ 61.15万
  • 项目类别:
Neutrophil Survival and Demise During Inflammatory States
炎症状态下中性粒细胞的存活和死亡
  • 批准号:
    10270899
  • 财政年份:
    2021
  • 资助金额:
    $ 61.15万
  • 项目类别:
Neutrophil Survival and Demise During Inflammatory States
炎症状态下中性粒细胞的存活和死亡
  • 批准号:
    10470243
  • 财政年份:
    2021
  • 资助金额:
    $ 61.15万
  • 项目类别:
Targeting inflammasome mediated disorders with green tea
用绿茶治疗炎症小体介导的疾病
  • 批准号:
    8084189
  • 财政年份:
    2010
  • 资助金额:
    $ 61.15万
  • 项目类别:
Targeting inflammasome mediated disorders with green tea
用绿茶治疗炎症小体介导的疾病
  • 批准号:
    7979296
  • 财政年份:
    2010
  • 资助金额:
    $ 61.15万
  • 项目类别:
Novel regulatory role of cryopyrin in inflammation
Cryopyrin 在炎症中的新调节作用
  • 批准号:
    6915149
  • 财政年份:
    2004
  • 资助金额:
    $ 61.15万
  • 项目类别:
Novel regulatory role of cryopyrin in inflammation
Cryopyrin 在炎症中的新调节作用
  • 批准号:
    6813842
  • 财政年份:
    2004
  • 资助金额:
    $ 61.15万
  • 项目类别:
The role of cryopyrin in autoinflammatory diseases
隐热蛋白在自身炎症性疾病中的作用
  • 批准号:
    6778348
  • 财政年份:
    2002
  • 资助金额:
    $ 61.15万
  • 项目类别:
The role of cryopyrin in autoinflammatory diseases
隐热蛋白在自身炎症性疾病中的作用
  • 批准号:
    6937116
  • 财政年份:
    2002
  • 资助金额:
    $ 61.15万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.15万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.15万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 61.15万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.15万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 61.15万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.15万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.15万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.15万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 61.15万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 61.15万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了